{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:08:08Z","timestamp":1788394088038,"version":"build-2803163510"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the Horizon2020 HTx project, this research aimed to form recommendations for critical barriers to patient involvement in HTA in CEE countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Built on previous research findings on potential barriers, a prioritisation survey was conducted online with CEE stakeholders. Recommendations for prioritised barriers were formed through a face-to-face workshop by CEE stakeholders and HTx experts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 105 stakeholders from 13 CEE countries completed the prioritisation survey and identified 12 of the 22 potential barriers as highly important. The workshop had 36 participants representing 9 CEE countries, and 5 Western European countries coming together to discuss solutions in order to form recommendations based on best practices, real-life experience, and transferability aspects. Stakeholder groups involved in both phases included HTA organisation representatives, payers, patients, caregivers, patient organisation representatives, patient experts, health care providers, academic and non-academic researchers, health care consultants and health technology manufacturers\/providers. As a result, 12 recommendations were formed specified to the CEE region\u2019s context, but potentially useful for a broader geographic audience.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this paper, we present 12 recommendations for meaningful, systematic, and sustainable patient involvement in HTA in CEE countries. Our hope is that engaging more than a hundred CEE stakeholders in the study helped to spread awareness of the importance and potential of patient involvement and that the resulting recommendations provide tangible steps for the way forward. Future studies shall focus on country-specific case studies of the implemented recommendations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1176200","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T04:48:55Z","timestamp":1688359735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Recommendations for patient involvement in health technology assessment in Central and Eastern European countries"],"prefix":"10.3389","volume":"11","author":[{"given":"Ivett","family":"Jakab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dimitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Hou\u00ffez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Bereczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"F\u00f6v\u00e9nyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorana","family":"Maravic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Belina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Andriciuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oresta","family":"Piniazhko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok","family":"Hren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Gutierrez-Ibarluzea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Czech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Niewada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Lorenzovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kamusheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoela","family":"Manova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Savova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zornitsa","family":"Mitkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Tachkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertalan","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna Ida","family":"Petyk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Dawoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Delnoij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Knies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Goettsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Kal\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/14737167.2020.1779061","article-title":"The transferability of health technology assessment-the European perspective with focus on central and eastern European countries","volume":"20","author":"N\u00e9meth","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S0266462320000215","article-title":"The new definition of health technology assessment: a milestone in international collaboration","volume":"36","author":"O'Rourke","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fmed.2018.00231","article-title":"EUPATI guidance for patient involvement in medicines research and development: health technology assessment","volume":"5","author":"Hunter","year":"2018","journal-title":"Front Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1017\/S0266462317000976","article-title":"Evaluation of patient and public involvement initiatives in health technology assessment: a survey of international agencies","volume":"33","author":"Weeks","year":"2017","journal-title":"Int J Technol Assess Health Care"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3389\/fpubh.2022.922708","article-title":"Potential barriers of patient involvement in health technology assessment in central and eastern European countries","volume":"10","author":"Dimitrova","year":"2022","journal-title":"Front Public Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.18553\/jmcp.2021.27.7.936","article-title":"Proposal for capturing patient experience through extended value frameworks of health technologies","volume":"27","author":"Inotai","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fmed.2018.00270","article-title":"EUPATI guidance for patient involvement in medicines research and development (R & D); guidance for pharmaceutical industry-led medicines R & D","volume":"5","author":"Warner","year":"2018","journal-title":"Front Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fmed.2018.00251","article-title":"EUPATI and patients in medicines research and development: guidance for patient involvement in ethical review of clinical trials","volume":"5","author":"Klingmann","year":"2018","journal-title":"Front Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-020-05442-9","article-title":"Patient-relevant outcomes: what are we talking about? A scoping review to improve conceptual clarity","volume":"20","author":"Kersting","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40271-019-00408-4","article-title":"Use of patient preference studies in HTA decision making: a NICE perspective","volume":"13","author":"Bouvy","year":"2020","journal-title":"Patient"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.healthpol.2021.03.006","article-title":"The role of patient experience in the value assessment of complex technologies\u2013do HTA bodies need to reconsider how value is assessed?","volume":"125","author":"Sarri","year":"2021","journal-title":"Health Policy"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"114048","DOI":"10.1016\/j.socscimed.2021.114048","article-title":"Valuing patient engagement: reflexive learning in evidence generation practices for health technology assessment","volume":"280","author":"Gunn","year":"2021","journal-title":"Soc Sci Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s43441-021-00282-z","article-title":"Sustaining meaningful patient engagement across the lifecycle of medicines: a roadmap for action","volume":"55","author":"Cavaller-Bellaubi","year":"2021","journal-title":"Ther Innov Regul Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1017\/S0266462321001768","article-title":"Integrating empirical analysis and normative inquiry in health technology assessment: the values in doing assessments of health technologies approach","volume":"38","author":"van der Wilt","year":"2022","journal-title":"Int J Technol Assess Health Care"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S0266462320001956","article-title":"Patient involvement interest Group of the Spanish Network for health technology assessment of the National Health System (RedETS). Development of a decisional flowchart for meaningful patient involvement in health technology assessment","volume":"37","author":"Toledo-Ch\u00e1varri","year":"2020","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1176200\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T04:48:57Z","timestamp":1688359737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1176200\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":15,"alternative-id":["10.3389\/fpubh.2023.1176200"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1176200","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"article-number":"1176200"}}